Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Human Vaccines
|
July 8, 2011
Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults
Daniela Toneatto, Philipp Oster, A Corine W deBoer, et al.
Ophthalmic Genetics
|
February 23, 2026
Streamlining the diagnostic and management pathways of patients with retinitis pigmentosa
Alan Kimura, Alina Dumitrescu, Emma C Bedoukian, et al.
JAMA
|
February 10, 2012
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial
Nicoletta Gossger, Matthew D Snape, Ly-Mee Yu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 15, 2010
Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
Joseph Muenzer, Michael Beck, Christine M Eng, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 17, 2006
A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
Joseph Muenzer, James E Wraith, Michael Beck, et al.
JAMA Ophthalmology
|
June 27, 2024
Anti-VEGF Pharmaceutical Prior Authorization in Retina Practices
Sabin Dang, D Wilkin Parke, Guneet S Sodhi, et al.
Retina (Philadelphia, Pa.)
|
February 22, 2017
INTRAVITREAL DEXAMETHASONE IMPLANT IN RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA
Ahmad M Mansour, Huda Sheheitli, Cem Kucukerdonmez, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Sequencing by Expansion (SBX) - a novel, high-throughput single-molecule sequencing technology
Mark Kokoris, Robert McRuer, Melud Nabavi, et al.
The Lancet. Infectious Diseases
|
November 26, 2021
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
Peter G Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana-Arri, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Human Vaccines
|
July 8, 2011
Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults
Daniela Toneatto, Philipp Oster, A Corine W deBoer, et al.
Ophthalmic Genetics
|
February 23, 2026
Streamlining the diagnostic and management pathways of patients with retinitis pigmentosa
Alan Kimura, Alina Dumitrescu, Emma C Bedoukian, et al.
JAMA
|
February 10, 2012
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial
Nicoletta Gossger, Matthew D Snape, Ly-Mee Yu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 15, 2010
Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
Joseph Muenzer, Michael Beck, Christine M Eng, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 17, 2006
A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
Joseph Muenzer, James E Wraith, Michael Beck, et al.
JAMA Ophthalmology
|
June 27, 2024
Anti-VEGF Pharmaceutical Prior Authorization in Retina Practices
Sabin Dang, D Wilkin Parke, Guneet S Sodhi, et al.
Retina (Philadelphia, Pa.)
|
February 22, 2017
INTRAVITREAL DEXAMETHASONE IMPLANT IN RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA
Ahmad M Mansour, Huda Sheheitli, Cem Kucukerdonmez, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Sequencing by Expansion (SBX) - a novel, high-throughput single-molecule sequencing technology
Mark Kokoris, Robert McRuer, Melud Nabavi, et al.
The Lancet. Infectious Diseases
|
November 26, 2021
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
Peter G Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana-Arri, et al.
Page
of 2